MAPK7 and metastatic melanoma: Another potential target is extracellular signal-regulated kinase 5 (ERK5) signalling since myeloid cell-selective knockout of ERK5 blocks TAM proliferation and metastatic tumour loads in a metastatic melanoma mouse model [59].